SILO
SILO
NASDAQ · Biotechnology

Silo Pharma Inc

$0.31
+0.02 (+6.55%)
As of Feb 8, 2:33 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 642.8K 653.1K 554.3K
Net Income 87.6K 116.0K 91.5K
EPS
Profit Margin 13.6% 17.8% 16.5%
Rev Growth +14.5% -9.1% -7.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 599.6K 583.1K 550.9K
Total Equity 1.90M 1.94M 1.85M
D/E Ratio 0.32 0.30 0.30
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 188.3K 172.6K 151.1K
Free Cash Flow 84.6K 101.3K 71.5K